| ANVRX | VIHAX | ANVRX / VIHAX | |
| Total Expense Ratio | 1.68 | 0.16 | 1,050% |
| Annual Report Gross Expense Ratio | 1.68 | 0.16 | 1,050% |
| Fund Existence | 7 years | 10 years | - |
| Gain YTD | 13.699 | 17.601 | 78% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 533M | 21.9B | 2% |
| Annual Yield % from dividends | 2.91 | 3.45 | 84% |
| Returns for 1 year | 14.50 | 25.96 | 56% |
| Returns for 3 years | 28.37 | 75.63 | 38% |
| Returns for 5 years | 31.64 | 66.41 | 48% |
| Returns for 10 years | N/A | 108.07 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RMOCX | 19.25 | 0.23 | +1.21% |
| Victory RS Mid Cap Growth C | |||
| CIVHX | 22.29 | 0.17 | +0.77% |
| American Funds Intl Vntg 529-F-3 | |||
| GSYPX | 45.93 | 0.22 | +0.48% |
| Goldman Sachs Small Cap Value P | |||
| PASTX | 68.29 | 0.18 | +0.26% |
| T. Rowe Price Science & Tech Adv | |||
| JMNCX | 12.25 | -0.01 | -0.08% |
| JPMorgan Research Market Neutral C | |||